Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma
Abstract Background Esophageal squamous cell carcinoma (ESCC) still remains intractable disease with few therapeutic options. Programmed death-ligand 1 (PD-L1), which is essential for immune evasion, is involved in the pathogenesis of ESCC and thus is a potential therapeutic target. PIK3CA, KRAS, an...
Saved in:
Main Authors: | Hong Kyu Lee (Author), Mi Jung Kwon (Author), Yong Joon Ra (Author), Hee Sung Lee (Author), Hyoung Soo Kim (Author), Eun Sook Nam (Author), Seong Jin Cho (Author), Hye-Rim Park (Author), Soo Kee Min (Author), Jinwon Seo (Author), Ji-Young Choe (Author), Kyueng-Whan Min (Author), So Young Kang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KRAS and BRAF Mutation in Borderline Epithelial Type Ovarian Tumor
by: Dodi Suardi
Published: (2013) -
Unilateral synchronous papillary renal neoplasm with reverse polarity and clear cell renal cell carcinoma: a case report with KRAS and PIK3CA mutations
by: Hyun Jung Lee, et al.
Published: (2020) -
KRAS and BRAF mutations in Iranian colorectal cancer patients: A systematic review and meta-analysis
by: Abolfazl Yari, et al.
Published: (2020) -
Pyrosequencing data analysis software: a useful tool for EGFR, KRAS, and BRAF mutation analysis
by: Shen Shanxiang, et al.
Published: (2012) -
Low frequency of BRAF and KRAS mutations in Chinese patients with low-grade serous carcinoma of the ovary
by: Yan Xu, et al.
Published: (2017)